Retaglutide is a innovative GLP-1 receptor agonist currently under study for the treatment of metabolic disorders. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://sidneynrja893674.blogpixi.com/39285599/retaglutide-a-promising-glp-1-receptor-agonist